Urinary incontinence and pelvic organ prolapse in women: management

Research recommendation(s) from an individual piece of guidance

Guidance:

Urinary incontinence and pelvic organ prolapse in women: management

Date issued:

02 April 2019

Research recommendations coming out of this guidance

• What is the effectiveness and safety of anticholinergic medicines for overactive bladder in older women?

• What is the effectiveness of colpocleisis compared with sacrospinous fixation for pelvic organ prolapse in elderly women?

• What is the effectiveness of ultrasound-guided visualisation compared with clinical assessment to identify complications after mesh surgery for stress urinary incontinence or pelvic organ prolapse in women?

• What are the long-term outcomes, including patient satisfaction, from the use of pessaries compared with surgery for pelvic organ prolapse in women?

• What are the long-term risks of mesh surgery compared with non-mesh surgery for stress urinary incontinence and pelvic organ prolapse in women?

• What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive bladder in women?

• What is the most effective surgical management for women with both stress urinary incontinence and pelvic organ prolapse, including the sequence of interventions?

• What is the effectiveness of pain management for women who present with chronic pain 3 months after mesh surgery for stress urinary incontinence or pelvic organ prolapse?